NEWS
- Nectin-4-Directed Drugs for Solid Tumors
- Recent Advances In Hematology 2022: ADCs, Bispecific Antibodies, CAR-T Cells…
- 9 Potential Blockbuster Drugs to be Approved in 2022
- Emerging Multiple Myeloma Therapies: mAbs, ADCs, CAR-T Cells & Bispecific Antibodies
- Antibody–Drug Conjugates for the Treatment of Breast Cancer
- Claudin18.2 Targeted Therapies In Cancer
- 10 Potential Blockbuster Drug Approvals in 2023
- FDA Approves Tivdak - First Tissue Factor (TF)-Targeted Antibody Conjugate Drug (ADC)
- Enhertu (Trastuzumab Deruxtecan): Magic ADC Drug
- PROTACs: Clinical Progress, Future Directions, Potential Challenges